Literature DB >> 23094986

Interleukin-6 receptor gene 48892 A/C polymorphism is associated with metabolic syndrome in female Taiwanese adolescents.

Chang-Hsun Hsieh1, Yi-Jen Hung, Ling-I Wu, Chih-Tsueng He, Chien-Hsing Lee, Fone-Ching Hsiao, Nain-Feng Chu.   

Abstract

BACKGROUND: This study was to evaluate the relationship between the interleukin-6 receptor (IL-6R) 48892 A/C single-nucleotide polymorphism (SNP) (rs8192284) and the metabolic syndrome (MetS) and its components among young adolescents in Taiwan.
METHODS: We enrolled 925 adolescents (451 boys and 474 girls). Modified National Cholesterol Education Program Adult Treatment Panel-III (NCEP ATP-III) criteria were applied to define MetS (with age- and gender-specific 90th percentile cutoff point of variables). Subjects had three or more of the following cardiometabolic abnormalities that occur in MetS: high blood pressure, high fasting glucose, high triglyceride (TG), low high-density lipoprotein cholesterol (HDL-C), and obesity. The characteristics of the MetS components associated with different alleles and genotypes of the IL-6R rs8192284 SNP were compared.
RESULTS: Frequencies of alleles and genotypes of the IL-6R 48892 polymorphism were similar in both sexes. Boys with C-alleles had borderline lower TG levels than A-allele carriers (66.0±30.1 vs. 70.3±34.6 mg/dL, p=0.07). However, girls with C-alleles had higher waist circumference (WC) (68.0±7.9 vs. 67.0±7.7 cm) and lower HDL-C levels (50.7±11.1 vs. 52.2±11.7 g/dL) than A-allele carriers (p=0.05). The prevalence of MetS and its components, high WC and low HDL-C level, were higher in female C-allele carriers (all p<0.05) but not in boys. The odds ratios for high WC, low HDL-C levels, and MetS for female C-allele carriers were 1.54 (95% confidence interval [CI]: 1.01-2.34), 1.49 (95% CI: 1.01-2.18), and 2.19-2.39 (95% CI: 1.15-4.51), respectively, when compared with A-allele carriers.
CONCLUSIONS: The IL-6R 48892 A/C polymorphism is associated with high TG and WC, and low HDL-C levels in adolescents. Additionally, there is a gender difference in the incidence of MetS, indicating a possible gene-gender interaction of the IL-6R 48892 A/C polymorphism in MetS among Taiwanese adolescents.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23094986      PMCID: PMC3501111          DOI: 10.1089/gtmb.2012.0188

Source DB:  PubMed          Journal:  Genet Test Mol Biomarkers        ISSN: 1945-0257


  31 in total

1.  Linkage and association mapping of a chromosome 1q21-q24 type 2 diabetes susceptibility locus in northern European Caucasians.

Authors:  Swapan Kumar Das; Sandra J Hasstedt; Zhengxian Zhang; Steven C Elbein
Journal:  Diabetes       Date:  2004-02       Impact factor: 9.461

2.  Elevated levels of interleukin 6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss.

Authors:  J P Bastard; C Jardel; E Bruckert; P Blondy; J Capeau; M Laville; H Vidal; B Hainque
Journal:  J Clin Endocrinol Metab       Date:  2000-09       Impact factor: 5.958

3.  Factors affecting the relationship between childhood and adult cholesterol levels: the Muscatine Study.

Authors:  R M Lauer; J Lee; W R Clarke
Journal:  Pediatrics       Date:  1988-09       Impact factor: 7.124

4.  The human interleukin-6 receptor alpha chain gene is localized on chromosome 1 band q21.

Authors:  P M Kluck; J Wiegant; R P Jansen; M W Bolk; A K Raap; R Willemze; J E Landegent
Journal:  Hum Genet       Date:  1993-01       Impact factor: 4.132

Review 5.  Obesity and cardiovascular disease risk factors in prepubescent and pubescent black and white females.

Authors:  F Falkner
Journal:  Crit Rev Food Sci Nutr       Date:  1993       Impact factor: 11.176

6.  Interleukin-6 receptor gene polymorphism modulates interleukin-6 levels and the metabolic syndrome: GBCS-CVD.

Authors:  Chao Qiang Jiang; Tai Hing Lam; Bin Liu; Jie Ming Lin; Xiao Jun Yue; Ya Li Jin; Bernard M Y Cheung; G Neil Thomas
Journal:  Obesity (Silver Spring)       Date:  2010-02-25       Impact factor: 5.002

7.  Interleukin-6-deficient mice develop mature-onset obesity.

Authors:  Ville Wallenius; Kristina Wallenius; Bo Ahrén; Mats Rudling; Hans Carlsten; Suzanne L Dickson; Claes Ohlsson; John-Olov Jansson
Journal:  Nat Med       Date:  2002-01       Impact factor: 53.440

8.  Variants in the interleukin 6 receptor gene are associated with obesity in Pima Indians.

Authors:  Johanna K Wolford; Peter B Colligan; Jonathan D Gruber; Clifton Bogardus
Journal:  Mol Genet Metab       Date:  2003-11       Impact factor: 4.797

9.  The soluble human IL-6 receptor. Mutational characterization of the proteolytic cleavage site.

Authors:  J Müllberg; W Oberthür; F Lottspeich; E Mehl; E Dittrich; L Graeve; P C Heinrich; S Rose-John
Journal:  J Immunol       Date:  1994-05-15       Impact factor: 5.422

10.  Interleukin-6 is an independent predictor of mortality in patients starting dialysis treatment.

Authors:  Roberto Pecoits-Filho; Peter Bárány; Bengt Lindholm; Olof Heimbürger; Peter Stenvinkel
Journal:  Nephrol Dial Transplant       Date:  2002-09       Impact factor: 5.992

View more
  1 in total

1.  KDR Amplification Is Associated with VEGF-Induced Activation of the mTOR and Invasion Pathways but does not Predict Clinical Benefit to the VEGFR TKI Vandetanib.

Authors:  Monique B Nilsson; Uma Giri; Jayanthi Gudikote; Ximing Tang; Wei Lu; Hai Tran; Youhong Fan; Andrew Koo; Lixia Diao; Pan Tong; Jing Wang; Roy Herbst; Bruce E Johnson; Andy Ryan; Alan Webster; Philip Rowe; Ignacio I Wistuba; John V Heymach
Journal:  Clin Cancer Res       Date:  2015-11-17       Impact factor: 12.531

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.